Tibet Weixinkang Medicine Co., Ltd. (SHA:603676)

China · Delayed Price · Currency is CNY

8.10

-0.14 (-1.70%)

Nov 13, 2026, 3:00 PM CST

Tibet Weixinkang Medicine Financials Overview

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	1,090	1,136	1,300	1,323	1,399	1,034
Revenue Growth	-6.71%	-12.65%	-1.70%	-5.43%	35.30%	44.43%
Gross Profit	637.71	693.34	695.98	671.41	726.48	530.92
Operating Income	142.37	219.67	222.43	145.07	154.54	92.92
Net Income	190.23	232.85	246.17	214.02	176.96	95.91
Earnings Per Share	0.44	0.54	0.57	0.50	0.41	0.23
EPS Growth	-15.03%	-5.26%	14.00%	21.95%	78.26%	64.29%

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	1,013	982.22	1,019	894.75	806.32	711.55
Total Debt	9.45	11.2	5.27	7.68	5.79	4.81
Net Cash (Debt)	1,003	971.02	1,014	887.07	800.53	706.73
Net Cash Growth	-0.54%	-4.25%	14.33%	10.81%	13.27%	22.80%
Net Cash Per Share	2.32	2.25	2.35	2.07	1.85	1.69

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	220.2	185.53	372.78	241.12	246.15	170.69
Capital Expenditures	-90.21	-83.92	-58.18	-70.81	-77.69	-55.6
Free Cash Flow	130	101.62	314.61	170.3	168.46	115.09
Free Cash Flow Growth	5.74%	-67.70%	84.73%	1.09%	46.37%	45.04%

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	58.51%	61.05%	53.53%	50.76%	51.95%	51.37%
Operating Margin	13.06%	19.34%	17.11%	10.97%	11.05%	8.99%
Pretax Margin	20.38%	24.97%	21.27%	16.32%	13.04%	11.05%
Profit Margin	17.45%	20.50%	18.93%	16.18%	12.65%	9.28%
FCF Margin	11.93%	8.95%	24.20%	12.88%	12.04%	11.13%

Dividends

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '26 Nov 13, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Dividend Per Share	0.327	0.327	0.342	0.285	0.235	0.160
Dividend Per Share Growth	-4.39%	-4.39%	20.00%	21.28%	46.88%	68.42%
Dividend Yield	4.04%	3.11%	3.42%	2.73%	1.48%	1.72%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '26 Nov 13, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	18.39	19.53	17.59	21.21	39.15	42.23
P/FCF Ratio	26.94	44.76	13.76	26.65	41.12	35.20
PS Ratio	3.21	4.01	3.33	3.43	4.95	3.92